Focal Therapeutics' Gail Lebovic to Be Honored by American Cancer Society
Press releases may be edited for formatting or style | July 18, 2012
LOS ANGELES -Gail Lebovic, MA, MD, FACS, is this year's recipient of the "Spirit of Achievement Award" from California Spirit, Southern California's largest gala fundraiser benefiting the American Cancer Society (ACS).
The award will be presented to Dr. Lebovic, who is the chief medical officer of Focal Therapeutics, at California Spirit 2012. The event will be held Sunday, July 29 at the Pacific Design Center, in West Hollywood www.calspirit.org.
Over the past 28 years, California Spirit has raised more than $14 million for ACS's lifesaving research, education, prevention and free patient-service programs. Founded in 1985 by Master Chef Wolfgang Puck, Sherry Lansing, and Barbara Lazaroff, California Spirit features gourmet cuisine, premium California wines, live entertainment, and a silent auction.
The Spirit of Achievement Award honors Dr. Lebovic for "her years of commitment to developing new techniques in the diagnosis, treatment and postoperative care of cancer patients, with a special focus on optimizing delivery of breast cancer care."
In addition to her pioneering clinical work as an Oncoplastic surgeon, Dr. Lebovic has founded numerous medical device companies and is one of a select group of women to hold numerous patents. She is internationally known as an inventor of the MammoPad™ and other innovative devices in women's healthcare.
Dr. Lebovic spent more than a decade as an attending surgeon at Stanford University Medical Center and later served as Associate Director of the Lee Breast Center at the University of Southern California and Director of Women's Healthcare at the Cooper Clinic in Dallas, Texas. She is past president of the American Society of Breast Disease (www.asbd.org).
"I've seen Gail's dedication to breast cancer patients firsthand, in her roles as both a clinician and the inventor of new technologies for diagnosing and treating the disease," said Thomas Fogarty, M.D., world-renowned physician and medical-device inventor who has worked with Dr. Lebovic for more than 15 years. "Her ability to translate patient needs into new tools that improve care is exceptional. She is the most outstanding female inventor I've had the privilege to work with."
George Hermann, CEO and lead engineer at Focal Therapeutics, noted that the team's most recent efforts show promise for many patients undergoing breast surgery. "We hope the new BioZorb™ tissue marker will be yet another significant technology in the field of breast healthcare that we have developed with Gail," he said.
About Focal Therapeutics
Focal Therapeutics is a medical device company based in Silicon Valley. The company's first product is the BioZorb™ tissue marker, a bioabsorbable device that provides radiographic marking of soft tissue sites. The BioZorb device is placed at the time of surgical removal of tissue, such as during breast surgery, and the device's three-dimensional array of marker elements has utility for clinical imaging. Focal Therapeutics is led by a seasoned team with a proven track record in the successful development and commercialization of medical products.
For more information about Focal Therapeutics, call 650-530-2394 or email info@focaltherapeutics.com.
The award will be presented to Dr. Lebovic, who is the chief medical officer of Focal Therapeutics, at California Spirit 2012. The event will be held Sunday, July 29 at the Pacific Design Center, in West Hollywood www.calspirit.org.
Over the past 28 years, California Spirit has raised more than $14 million for ACS's lifesaving research, education, prevention and free patient-service programs. Founded in 1985 by Master Chef Wolfgang Puck, Sherry Lansing, and Barbara Lazaroff, California Spirit features gourmet cuisine, premium California wines, live entertainment, and a silent auction.
The Spirit of Achievement Award honors Dr. Lebovic for "her years of commitment to developing new techniques in the diagnosis, treatment and postoperative care of cancer patients, with a special focus on optimizing delivery of breast cancer care."
In addition to her pioneering clinical work as an Oncoplastic surgeon, Dr. Lebovic has founded numerous medical device companies and is one of a select group of women to hold numerous patents. She is internationally known as an inventor of the MammoPad™ and other innovative devices in women's healthcare.
Dr. Lebovic spent more than a decade as an attending surgeon at Stanford University Medical Center and later served as Associate Director of the Lee Breast Center at the University of Southern California and Director of Women's Healthcare at the Cooper Clinic in Dallas, Texas. She is past president of the American Society of Breast Disease (www.asbd.org).
"I've seen Gail's dedication to breast cancer patients firsthand, in her roles as both a clinician and the inventor of new technologies for diagnosing and treating the disease," said Thomas Fogarty, M.D., world-renowned physician and medical-device inventor who has worked with Dr. Lebovic for more than 15 years. "Her ability to translate patient needs into new tools that improve care is exceptional. She is the most outstanding female inventor I've had the privilege to work with."
George Hermann, CEO and lead engineer at Focal Therapeutics, noted that the team's most recent efforts show promise for many patients undergoing breast surgery. "We hope the new BioZorb™ tissue marker will be yet another significant technology in the field of breast healthcare that we have developed with Gail," he said.
About Focal Therapeutics
Focal Therapeutics is a medical device company based in Silicon Valley. The company's first product is the BioZorb™ tissue marker, a bioabsorbable device that provides radiographic marking of soft tissue sites. The BioZorb device is placed at the time of surgical removal of tissue, such as during breast surgery, and the device's three-dimensional array of marker elements has utility for clinical imaging. Focal Therapeutics is led by a seasoned team with a proven track record in the successful development and commercialization of medical products.
For more information about Focal Therapeutics, call 650-530-2394 or email info@focaltherapeutics.com.
You Must Be Logged In To Post A CommentRegisterRegistration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now! |
|
